Related Experiment Videos
Summary
Pediatric renal parenchymal carcinoma presents similarly to adult forms but has an equal sex ratio. Treatment involves nephrectomy, with radiotherapy and chemotherapy beneficial for local spread, improving the 5-year survival rate to 52%.
Area of Science:
- Pediatric Oncology
- Nephrology
- Urologic Oncology
Background:
- Renal parenchymal carcinoma is rare in patients under 20.
- Understanding its unique characteristics in pediatric populations is crucial for effective management.
Purpose of the Study:
- To present and review cases of pediatric renal parenchymal carcinoma.
- To compare its features, treatment, and prognosis with adult renal tumors.
Main Methods:
- Review of 14 pediatric cases.
- Literature review of documented case reports.
- Analysis of clinical presentation, treatment modalities, and outcomes.
Main Results:
- Equal sex ratio observed in pediatric cases, unlike adult counterparts.
- Minor trauma frequently precipitates presentation in children.
- Nephrectomy is the primary treatment; radiotherapy and chemotherapy show value for local spread.
- Cellular granularity and extrarenal spread significantly worsen prognosis.
Conclusions:
- Pediatric renal parenchymal carcinoma exhibits distinct epidemiological features.
- Adjuvant therapies are valuable in managing local spread in pediatric patients.
- The overall 5-year survival rate is 52%, highlighting the need for improved treatment strategies.